Clinical Trials Browser

Phase 2 × N-Methyl-3,4-methylenedioxyamphetamine × 90 days × Clear all

NCT05584826 2026-05-04

MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other

Phase 2 Recruiting

Adjustment Disorders, Neoplasms